1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Larynx: new trials by email Literature Review of Larynx trials Research Report on Larynx
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Window of Opportunity Trial of Durvalumab (MEDI4736) or Durvalumab/Tremelimumab as Neoadjuvant Chemotherapy to Identify Immune Dynamics in Surgically Resectable Head and Neck Cancer Patients. Durvalumab, durvalumab + tremelimumab - Stage II-IVB Operable HNSCC Oral Cavity, Hypopharynx | Phase 2 | Unknown | Yonsei University | 48 | 2019-01-02 | 2023-03-21 |
Otorhinolaryngologic Diseases (1) · Respiratory Tract Diseases (1)
durvalumab (1) · tremelimumab (1)
South Korea (1)